KINIKSA PHARMACEUTICALS INTL

Ticker: KNSA CUSIP: G52694109 Class: Common Stock

RHUMBLINE ADVISERS's Holding History (CIK: 0001115418)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 7,286 Value ($000) $301 Avg Close $40.11 Range $35.20 - $44.42

Q3 2025

Shares 7,286 Value ($000) $283 Avg Close $32.49 Range $26.27 - $39.00

Q2 2025

Shares 7,286 Value ($000) $202 Avg Close $25.46 Range $18.25 - $30.69

Q1 2025

Shares 62,700 Value ($000) $1,393 Avg Close $20.58 Range $17.82 - $24.31

Q4 2024

Shares 58,955 Value ($000) $1,166 Avg Close $22.82 Range $19.47 - $28.15

Q3 2024

Shares 59,864 Value ($000) $1,496 Avg Close $24.36 Range $17.38 - $27.92

Q2 2024

Shares 56,066 Value ($000) $1,047 Avg Close $18.73 Range $16.56 - $20.52

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	7,286	$301	$40.11	$35.20 - $44.42
Q3 2025	7,286	$283	$32.49	$26.27 - $39.00
Q2 2025	7,286	$202	$25.46	$18.25 - $30.69
Q1 2025	62,700	$1,393	$20.58	$17.82 - $24.31
Q4 2024	58,955	$1,166	$22.82	$19.47 - $28.15
Q3 2024	59,864	$1,496	$24.36	$17.38 - $27.92
Q2 2024	56,066	$1,047	$18.73	$16.56 - $20.52